Image from Google Jackets

Gliomas : symptoms, diagnosis and treatment options [E-Book]

Contributor(s): Series: Cancer etiology, diagnosis, and treatmentsPublisher: New York : Nova Biomedical, [2013]Description: 1 online resourceContent type:
  • text
Media type:
  • computer
Carrier type:
  • online resource
ISBN:
  • 9781626181069
  • 1626181063
Subject(s): Online resources:
Contents:
GLIOMAS: SYMPTOMS, DIAGNOSIS AND TREATMENT OPTIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; INTRODUCTION; SECTION I. SYMPTOMS AND DIAGNOSIS; Chapter 1: EPIDEMIOLOGY OF GLIOMAS; ABSTRACT; INTRODUCTION; INCIDENCE AND MORTALITY; GENETIC FACTORS; ADULT STATURE AND BODY WEIGHT; HORMONAL AND REPRODUCTIVE FACTORS; ALLERGIES AND OTHER MEDICAL CONDITIONS; SMOKING AND ALCOHOL; N-NITROSO COMPOUNDS AND OTHER DIETARY FACTORS; IONIZING RADIATION; CELL PHONE USE; CONCLUSION; REFERENCES; Chapter 2: PATHOLOGY OF GLIOMAS; ABSTRACT; INTRODUCTION; ASTROCYTIC TUMORS; OLIGODENDROGLIAL TUMORS.
CONCLUSIONREFERENCES; Chapter 3: MOLECULAR GENETICS OF BRAIN TUMORS; ABSTRACT; INTRODUCTION; TUMOR SUPPRESSORS, ONCOGENES AND MUTATOR GENES; MUTATIONS THAT UNDERLIE BRAIN TUMORS; GLIOBLASTOMAS; LOW-GRADE ASTROCYTOMAS AND OLIGODENDROGLIOMAS; MEDULLOBLASTOMAS; SUMMARY: PERSPECTIVES IN BRAIN TUMORS GENOMICS; REFERENCES; Chapter 4: CLINICAL FEATURES OF CENTRAL NERVOUS SYSTEM TUMORS; ABSTRACT; INTRODUCTION; CLINICAL PRESENTATION; CONCLUSION; REFERENCES; Chapter 5: NEURO IMAGING OF MALIGNANT GLIOMAS; ABSTRACT; INTRODUCTION; PERFUSION IMAGING; SPECTROSCOPY; DIFFUSION WEIGHTED IMAGING.
BRAIN MAPPING WITH FUNCTIONAL MRI (FMRI)CONCLUSION; REFERENCES; Chapter 6: INTRA-OPERATIVE BRAIN MAPPING IN GLIOMA SURGERY; ABSTRACT; INTRODUCTION; LOCALIZATION OF HUMAN CORTICAL AND SUBCORTICAL FUNCTION; TUMOR AND FUNCTION LOCALIZATION; PREOPERATIVE CONSIDERATIONS; INTRAOPERATIVE MAPPING TECHNIQUES; CONCLUSIONS; REFERENCES; Chapter 7: PREOPERATIVE BRAIN MAPPING IN GLIOMA SURGERY; ABSTRACT; INTRODUCTION; METHODS OF BRAIN MAPPING: ADVANCES AND LIMITATIONS; CONCLUSION; REFERENCES; SECTION II. CURRENT TREATMENT OPTIONS; Chapter 8: NEUROLOGICAL COMPLICATIONS OF GLIOMAS; ABSTRACT; I. INTRODUCTION.
CONCLUSIONREFERENCES; Chapter 9: RADIATION THERAPY IN THE MANAGEMENT OF GLIOMA; ABSTRACT; I. INTRODUCTION; II. RADIOTHERAPY FOR HIGH GRADE GLIOMAS; III. RADIOTHERAPY FOR LOW GRADE GLIOMAS; IV. ADVERSE EFFECTS OF RADIATION THERAPY; V. ADDITIONAL TOPICS; CONCLUSION; REFERENCES; Chapter 10: DOSE RATE MODULATION FOR THE SAFE DELIVERY OF RETREATMENT IRRADIATION IN RECURRENT GLIOMA PATIENTS; ABSTRACT; 1. INTRODUCTION; 2. THE BILOGICAL BASIS FOR DOSE RATE MODULATION; 3. TECHNIQUES FOR THE CLINICAL APPLICATION OF REDUCED -- DOSE-RATE EXTERNAL BEAM RADIOTHERAPY.
4. CLINICAL EXPERENCE FOR DOSE RATE MODULATION AS RECURENT GLIOMA THERAPYCONCLUSION; REFERENCES; Chapter 11: TARGETED THERAPIES FOR MALIGNANT GLIOMAS; ABSTRACT; INTRODUCTION; CHEMOTHERAPY; ALKYLATING AGENTS; MOLECULAR TARGETED THERAPIES; ANTIANGIOGENIC THERAPIES; OTHER MOLECULAR TARGETED THERAPIES; EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS; PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR)INHIBITORS; INTRACELLULAR SIGNALING PATHWAY INHIBITORS; HISTONE DEACETYLASE (HDAC) INHIBITORS; RESISTANCE TO TARGETED THERAPY AND THE ROLE OF STEM CELLS; TARGETING GLIOMA STEM CELLS; CONCLUSION.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Home library Class number URL Status Date due Barcode
Electronic book Stenhouse Library Link to resource Available

Includes bibliographical references and index.

Description based on print version record.

GLIOMAS: SYMPTOMS, DIAGNOSIS AND TREATMENT OPTIONS; Library of Congress Cataloging-in-Publication Data; CONTENTS; INTRODUCTION; SECTION I. SYMPTOMS AND DIAGNOSIS; Chapter 1: EPIDEMIOLOGY OF GLIOMAS; ABSTRACT; INTRODUCTION; INCIDENCE AND MORTALITY; GENETIC FACTORS; ADULT STATURE AND BODY WEIGHT; HORMONAL AND REPRODUCTIVE FACTORS; ALLERGIES AND OTHER MEDICAL CONDITIONS; SMOKING AND ALCOHOL; N-NITROSO COMPOUNDS AND OTHER DIETARY FACTORS; IONIZING RADIATION; CELL PHONE USE; CONCLUSION; REFERENCES; Chapter 2: PATHOLOGY OF GLIOMAS; ABSTRACT; INTRODUCTION; ASTROCYTIC TUMORS; OLIGODENDROGLIAL TUMORS.

CONCLUSIONREFERENCES; Chapter 3: MOLECULAR GENETICS OF BRAIN TUMORS; ABSTRACT; INTRODUCTION; TUMOR SUPPRESSORS, ONCOGENES AND MUTATOR GENES; MUTATIONS THAT UNDERLIE BRAIN TUMORS; GLIOBLASTOMAS; LOW-GRADE ASTROCYTOMAS AND OLIGODENDROGLIOMAS; MEDULLOBLASTOMAS; SUMMARY: PERSPECTIVES IN BRAIN TUMORS GENOMICS; REFERENCES; Chapter 4: CLINICAL FEATURES OF CENTRAL NERVOUS SYSTEM TUMORS; ABSTRACT; INTRODUCTION; CLINICAL PRESENTATION; CONCLUSION; REFERENCES; Chapter 5: NEURO IMAGING OF MALIGNANT GLIOMAS; ABSTRACT; INTRODUCTION; PERFUSION IMAGING; SPECTROSCOPY; DIFFUSION WEIGHTED IMAGING.

BRAIN MAPPING WITH FUNCTIONAL MRI (FMRI)CONCLUSION; REFERENCES; Chapter 6: INTRA-OPERATIVE BRAIN MAPPING IN GLIOMA SURGERY; ABSTRACT; INTRODUCTION; LOCALIZATION OF HUMAN CORTICAL AND SUBCORTICAL FUNCTION; TUMOR AND FUNCTION LOCALIZATION; PREOPERATIVE CONSIDERATIONS; INTRAOPERATIVE MAPPING TECHNIQUES; CONCLUSIONS; REFERENCES; Chapter 7: PREOPERATIVE BRAIN MAPPING IN GLIOMA SURGERY; ABSTRACT; INTRODUCTION; METHODS OF BRAIN MAPPING: ADVANCES AND LIMITATIONS; CONCLUSION; REFERENCES; SECTION II. CURRENT TREATMENT OPTIONS; Chapter 8: NEUROLOGICAL COMPLICATIONS OF GLIOMAS; ABSTRACT; I. INTRODUCTION.

CONCLUSIONREFERENCES; Chapter 9: RADIATION THERAPY IN THE MANAGEMENT OF GLIOMA; ABSTRACT; I. INTRODUCTION; II. RADIOTHERAPY FOR HIGH GRADE GLIOMAS; III. RADIOTHERAPY FOR LOW GRADE GLIOMAS; IV. ADVERSE EFFECTS OF RADIATION THERAPY; V. ADDITIONAL TOPICS; CONCLUSION; REFERENCES; Chapter 10: DOSE RATE MODULATION FOR THE SAFE DELIVERY OF RETREATMENT IRRADIATION IN RECURRENT GLIOMA PATIENTS; ABSTRACT; 1. INTRODUCTION; 2. THE BILOGICAL BASIS FOR DOSE RATE MODULATION; 3. TECHNIQUES FOR THE CLINICAL APPLICATION OF REDUCED -- DOSE-RATE EXTERNAL BEAM RADIOTHERAPY.

4. CLINICAL EXPERENCE FOR DOSE RATE MODULATION AS RECURENT GLIOMA THERAPYCONCLUSION; REFERENCES; Chapter 11: TARGETED THERAPIES FOR MALIGNANT GLIOMAS; ABSTRACT; INTRODUCTION; CHEMOTHERAPY; ALKYLATING AGENTS; MOLECULAR TARGETED THERAPIES; ANTIANGIOGENIC THERAPIES; OTHER MOLECULAR TARGETED THERAPIES; EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS; PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR)INHIBITORS; INTRACELLULAR SIGNALING PATHWAY INHIBITORS; HISTONE DEACETYLASE (HDAC) INHIBITORS; RESISTANCE TO TARGETED THERAPY AND THE ROLE OF STEM CELLS; TARGETING GLIOMA STEM CELLS; CONCLUSION.

Master record variable field(s) change: 650

There are no comments on this title.

to post a comment.
London Health Libraries Koha Consortium privacy notice